Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1998
10/28/1998CN1196954A Compound ginkgo leaf prepn. and its prepn. method
10/28/1998CN1196946A Prodn. of infarct for eliminating haemorrhoids
10/28/1998CN1196938A Ointment for treating child' cold and cough, and its prepn. method
10/28/1998CN1196934A External-use skeleton powder and its prepn. method
10/28/1998CN1196933A External-use drops for ear and its prepn. method
10/28/1998CN1196932A Oral application of (+)-0-demethyltramadol as pain-killing drug
10/28/1998CN1196931A Aqueous solvent based encapsulation of bovine herpes virus type-1 subunit vaccine
10/28/1998CN1196930A Drug delivery system for twor or more active substance
10/28/1998CN1196929A Production of solid combination drug forms
10/28/1998CN1196928A Nanoemulsion based on nonionic amphiphilic lipids and aminated silicones and uses
10/28/1998CN1196927A Chemical composition
10/28/1998CN1196880A Use of encapsulated bioactive composition
10/28/1998CN1040395C External-use medicine with skin care and beautifying function
10/28/1998CN1040394C Anti-microbe compsn. for dental use and toothbrush coated the same
10/28/1998CA2203843A1 Liposome-encapsulated poly iclc
10/27/1998US5827984 Apparatus for simulating the effect of the living organism on the change in shape, the disintegration and dissolution behaviour and the active-ingredient release of a pharmaceutical dosage form
10/27/1998US5827852 Coated pharmaceutical compositions
10/27/1998US5827850 1,2,4-benzotriazine oxides formulations
10/27/1998US5827835 Thermally-gelling emulsions
10/27/1998US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
10/27/1998US5827831 Lipid nucleotide analog prodrugs for oral administration
10/27/1998US5827822 Aqueous suspension of cyclosporin particles and polyoxyethylene glycol surfactant
10/27/1998US5827818 Anticoagulants; administered by injections along with a carrier
10/27/1998US5827707 Method for manufacturing minimal volume capsules containing biological materials
10/27/1998US5827703 Methods and composition for in vivo gene therapy
10/27/1998US5827652 Stereoisomers; treatment of macular degeneration
10/27/1998US5827563 Fondant cream containing polycrystalline sugar having uniform controlled particle size and three-dimensional structure
10/27/1998US5827545 Veterinary pharmaceutical composition and method of administration
10/27/1998US5827541 Forming suspension of hydrophobic substance in solvent containing surfactant and water-soluble or dispersible carrier, forming units, removing solvent
10/27/1998US5827539 Dry carotenoid-oil powder and process for making same
10/27/1998US5827538 Controlled release of the water-insoluble core after imbibement of water vapor and wetting of a porous wall of semipermeable hydrophobic membrane impervious to liquid water; drug delivery
10/27/1998US5827537 Pharmaceutical thermal infusion process
10/27/1998US5827536 Anticholesterol drug solution comprising a solubilizer nonionic surfactant diethylene glycol monoethyl ether
10/27/1998US5827535 Graphically impressed softgel and method for making same
10/27/1998US5827533 Liposomes containing active agents aggregated with lipid surfactants
10/27/1998US5827532 Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations
10/27/1998US5827531 Microcapsules and methods for making
10/27/1998US5827530 Fillable patch for dermal or transdermal delivery
10/27/1998US5827529 External preparation for application to the skin containing lidocaine
10/27/1998US5827525 Buccal delivery system for therapeutic agents
10/27/1998US5827520 Vehicle and composition containing this vehicle and a stabilized cosmetic or dermatological active substance
10/27/1998US5827512 Method for the treatment of bronchial asthma and like hypersensitivity diseases by administration of anionic polymers
10/27/1998US5827245 Using crystals and a gas-tight, sealed packing with dehydrating water-absorbing substance, storage stability; increased diffusion
10/27/1998CA2039869C Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
10/27/1998CA2038331C Composition for the comestic and/or pharmaceutic treatment of the superior layers of the skin by topical application on the skin and corresponding preparation process
10/23/1998CA2229430A1 Aqueous solvent based encapsulation of bovine herpes virus type-1 subunit vaccine
10/22/1998WO1998046732A1 Controlled dissolution cross-linked protein crystals
10/22/1998WO1998046655A1 Methacrylic polymer having terminal functional group and composition thereof
10/22/1998WO1998046648A1 Interactive system for substance presentation and elimination
10/22/1998WO1998046598A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods
10/22/1998WO1998046348A1 Heat resistant lipid vesicles
10/22/1998WO1998046325A1 Microfabricated filter and capsule formed by substrates
10/22/1998WO1998046287A2 Drug delivery via therapeutic hydrogels
10/22/1998WO1998046286A1 Biodegradable compounds, compositions, articles and methods for making and using the same
10/22/1998WO1998046273A2 Delivery system for gene therapy to the brain
10/22/1998WO1998046270A2 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998WO1998046269A1 Permucous preparation
10/22/1998WO1998046267A1 Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition
10/22/1998WO1998046261A1 Vaginal lactobacillus medicant
10/22/1998WO1998046257A1 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
10/22/1998WO1998046253A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998WO1998046243A2 Pharmaceutical compositions having appetite suppressant activity
10/22/1998WO1998046239A1 Extended release formulations of erythromycin derivatives
10/22/1998WO1998046237A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998WO1998046235A1 Analgesic combination
10/22/1998WO1998046215A1 Rapidly dissolving robust dosage form
10/22/1998WO1998046214A1 Pharmaceutical tablet of amiodarone salt
10/22/1998WO1998046213A1 Cefadroxil monohydrate tablet formulation
10/22/1998WO1998046212A1 Biodegradable microparticles for the sustained delivery of therapeutic drugs
10/22/1998WO1998046211A1 Sustained-release alginate gels
10/22/1998WO1998046210A1 Method and composition for targeted delivery of compounds
10/22/1998WO1998046209A1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration
10/22/1998WO1998046208A1 Hair follicle dna delivery system
10/22/1998WO1998046204A1 Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
10/22/1998WO1998046200A1 Delivery systems for active ingredients including sunscreen actives and methods of making same
10/22/1998WO1998046199A1 Method for making a product adhere to a surface
10/22/1998WO1998046176A1 A transurethral device
10/22/1998WO1998046077A1 A method for treating papillomavirus infections
10/22/1998WO1998036732A3 Combination preparation for orally administered antibiotics
10/22/1998WO1998032463A3 Lyophilizate of lipid complex of water insoluble porphyrins
10/22/1998WO1998002190A3 Cationic amphiphile/dna complexes
10/22/1998DE19716154A1 Stabile pharmazeutische Darreichungsform für Peptide, Proteine und Nukleinsäuren The stable pharmaceutical dosage form of peptides, proteins and nucleic acids
10/22/1998DE19715594A1 Analgetika-Kombination Analgesic combination
10/22/1998CA2634700A1 Drug delivery via therapeutic hydrogels
10/22/1998CA2584411A1 Pharmaceutical compositions having appetite suppressant activity
10/22/1998CA2465698A1 Extended release formulations of erythromycin derivatives
10/22/1998CA2288968A1 Permucous preparation
10/22/1998CA2288284A1 Use of at least one irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
10/22/1998CA2287463A1 Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition
10/22/1998CA2287398A1 Methacrylic polymer having a terminal functional group and composition thereof
10/22/1998CA2286904A1 Pharmaceutical tablet of amiodarone salt
10/22/1998CA2286791A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998CA2286692A1 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998CA2286461A1 Controlled dissolution cross-linked protein crystals
10/22/1998CA2286181A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods
10/22/1998CA2286079A1 Cefadroxil monohydrate tablet formulation
10/22/1998CA2286070A1 A transurethral device
10/22/1998CA2285950A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998CA2285572A1 A method for treating papillomavirus infections
10/22/1998CA2285528A1 Delivery systems for active ingredients including sunscreen actives and methods of making same
1 ... 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 ... 2991